UBS Group

UBS Group Portfolio holdings

AUM $478B
1-Year Return 17.78%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Quarter Return
+5.78%
1 Year Return
+17.78%
3 Year Return
+59.77%
5 Year Return
+91.78%
10 Year Return
+181.19%
AUM
$217B
AUM Growth
+$8.33B
Cap. Flow
-$2.95B
Cap. Flow %
-1.36%
Top 10 Hldgs %
16.88%
Holding
10,256
New
758
Increased
3,648
Reduced
3,810
Closed
1,799

Sector Composition

1 Technology 15.53%
2 Financials 10.21%
3 Healthcare 8.53%
4 Consumer Discretionary 6.37%
5 Industrials 5.75%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
TNON icon
7126
Tenon Medical
TNON
$11M
$3.66K ﹤0.01%
26
-5
-16% -$704
SPDV icon
7127
AAM S&P 500 High Dividend Value ETF
SPDV
$74.7M
$3.64K ﹤0.01%
129
-1,581
-92% -$44.6K
OXBR icon
7128
Oxbridge Re Holdings
OXBR
$18.5M
$3.62K ﹤0.01%
2,071
-3,747
-64% -$6.56K
GCMGW icon
7129
GCM Grosvenor Inc. Warrant
GCMGW
$38.9M
$3.61K ﹤0.01%
6,400
+1,269
+25% +$716
IAF
7130
abrdn Australia Equity Fund
IAF
$127M
$3.61K ﹤0.01%
822
-2,342
-74% -$10.3K
BLTE
7131
Belite Bio
BLTE
$2.41B
$3.59K ﹤0.01%
120
-4,097
-97% -$123K
IPHA
7132
Innate Pharma
IPHA
$179M
$3.59K ﹤0.01%
1,259
+1,113
+762% +$3.17K
DXF
7133
Eason Technology Limited American Depositary Shares (each representing sixty-thousand (60,000) Ordinary Shares)
DXF
$1.1M
$3.58K ﹤0.01%
2,506
-3,556
-59% -$5.09K
LUCD icon
7134
Lucid Diagnostics
LUCD
$109M
$3.58K ﹤0.01%
2,558
-1,007
-28% -$1.41K
RLMD icon
7135
Relmada Therapeutics
RLMD
$54.8M
$3.57K ﹤0.01%
1,578
-4,335
-73% -$9.8K
ORKA
7136
Oruka Therapeutics, Inc. Common Stock
ORKA
$621M
$3.56K ﹤0.01%
149
+24
+19% +$573
KRMD icon
7137
KORU Medical Systems
KRMD
$187M
$3.55K ﹤0.01%
+842
New +$3.55K
RC.PRC
7138
Ready Capital Corporation 6.25% Series C Cumulative Convertible Preferred Stock
RC.PRC
$5.73M
$3.55K ﹤0.01%
+200
New +$3.55K
MTEX icon
7139
Mannatech
MTEX
$16M
$3.54K ﹤0.01%
205
-1,151
-85% -$19.9K
SQEW icon
7140
LeaderShares Equity Skew ETF
SQEW
$55.1M
$3.54K ﹤0.01%
122
+79
+184% +$2.29K
ORN icon
7141
Orion Group Holdings
ORN
$323M
$3.54K ﹤0.01%
1,365
-3,635
-73% -$9.41K
ACOR
7142
DELISTED
Acorda Therapeutics, Inc.
ACOR
$3.53K ﹤0.01%
301
-364
-55% -$4.27K
SPXT icon
7143
ProShares S&P 500 ex-Technology ETF
SPXT
$220M
$3.53K ﹤0.01%
51
-515
-91% -$35.6K
JJS
7144
DELISTED
iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN
JJS
$3.52K ﹤0.01%
54
+25
+86% +$1.63K
GFOF
7145
DELISTED
Grayscale Future of Finance ETF
GFOF
$3.52K ﹤0.01%
329
-3,502
-91% -$37.4K
FSEC icon
7146
Fidelity Investment Grade Securitized ETF
FSEC
$4.16B
$3.52K ﹤0.01%
82
+74
+925% +$3.17K
INKT icon
7147
MiNK Therapeutics
INKT
$69.4M
$3.51K ﹤0.01%
185
-65
-26% -$1.23K
AGIL
7148
DELISTED
AgileThought, Inc. Class A Common Stock
AGIL
$3.51K ﹤0.01%
1,113
-2,832
-72% -$8.92K
INVZ icon
7149
Innoviz Technologies
INVZ
$396M
$3.5K ﹤0.01%
1,000
NB
7150
NioCorp Developments
NB
$446M
$3.5K ﹤0.01%
+550
New +$3.5K